Goldenwell Biotech, INC. (GWLL) — 10-Q Filings

10-Q Filings (6)

• Goldenwell Biotech Narrows Losses, Boosts Service Revenue Amidst Going Concern — Dec 8, 2025 Risk: high
  GOLDENWELL BIOTECH, INC. (GWLL) reported a net loss of $47,581 for the nine months ended September 30, 2025, a significant improvement from the $103,962 net los
• Goldenwell Biotech Narrows Losses, Still Faces Going Concern Doubts — Sep 12, 2025 Risk: high
  GOLDENWELL BIOTECH, INC. (GWLL) reported a net loss of $39,596 for the six months ended June 30, 2025, a significant improvement from the $80,897 net loss in th
• Goldenwell Biotech Bets Big on Megalight Acquisition for Future Growth — May 27, 2025 Risk: high
  GOLDENWELL BIOTECH, INC. (GWLL) reported no revenue for the quarter ended March 31, 2025, consistent with the prior year's quarter. The company's net income was
• Goldenwell Biotech Files Q3 2024 10-Q — Nov 26, 2024 Risk: medium
  Goldenwell Biotech, Inc. filed its Q3 2024 10-Q report on November 26, 2024, covering the period ending September 30, 2024. The company, incorporated in Nevada,
• Goldenwell Biotech Files Q2 2024 10-Q — Aug 22, 2024 Risk: low
  Goldenwell Biotech, Inc. filed its 10-Q for the period ending June 30, 2024. The company, incorporated in Nevada and operating in the food and kindred products
• Goldenwell Biotech Q1 2024: $300M Assets, $99M Liabilities — May 20, 2024 Risk: medium
  Goldenwell Biotech, Inc. filed its Q1 2024 10-Q report on May 20, 2024, for the period ending March 31, 2024. The company's business address is 581 Boston Mills

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX